Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients

ABSTRACT There is substantial evidence that stool culture and parasitological examinations are of minimal to no value after 3 days of hospitalization. We implemented and studied the impact of a clinical decision support tool (CDST) to decrease the number of unnecessary stool cultures (STCUL), ova/parasite (O&P) examinations, and Giardia/Cryptosporidium enzyme immunoassay screens (GC-EIA) performed for patients hospitalized >3 days. We studied the frequency of stool studies ordered before or on day 3 and after day 3 of hospitalization (i.e., categorical orders/total number of orders) before and after this intervention and denoted the numbers and types of microorganisms detected within those time frames. This intervention, which corresponded to a custom-programmed hard-stop alert tool in the Epic hospital information system, allowed providers to override the intervention by calling the laboratory, if testing was deemed medically necessary. Comparative statistics were employed to determine significance, and cost savings were estimated based on our internal costs. Before the intervention, 129/670 (19.25%) O&P examinations, 47/204 (23.04%) GC-EIA, and 249/1,229 (20.26%) STCUL were ordered after 3 days of hospitalization. After the intervention, 46/521 (8.83%) O&P examinations, 27/157 (17.20%) GC-EIA, and 106/1,028 (10.31%) STCUL were ordered after 3 days of hospitalization. The proportions of reductions in the number of tests performed after 3 days and the associated P values were 54.1% for O&P examinations (P < 0.0001), 22.58% for GC-EIA (P = 0.2807), and 49.1% for STCUL (P < 0.0001). This was estimated to have resulted in $8,108.84 of cost savings. The electronic CDST resulted in a substantial reduction in the number of evaluations of stool cultures and the number of parasitological examinations for patients hospitalized for more than 3 days and in a cost savings while retaining the ability of the clinician to obtain these tests if clinically indicated.

[1]  Jacquelyn D. Riley,et al.  Improving Molecular Genetic Test Utilization through Order Restriction, Test Review, and Guidance. , 2015, The Journal of molecular diagnostics : JMD.

[2]  The Dream of Value-Based Care. , 2017, American health & drug benefits.

[3]  H. G. Morgan,et al.  Emergency Biochemistry Services—Are They Abused? , 1982, Annals of clinical biochemistry.

[4]  A Robinson,et al.  Rationale for cost-effective laboratory medicine , 1994, Clinical Microbiology Reviews.

[5]  N. Uemura,et al.  Validation of the 3-day rule for stool bacterial tests in Japan. , 2014, Internal medicine.

[6]  J. Balog.  The Meaning of Health in the Era of Value-based Care , 2017, Cureus.

[7]  Michael L Wilson,et al.  Application of rejection criteria for stool ovum and parasite examinations , 1992, Journal of clinical microbiology.

[8]  P. Valenstein,et al.  The use and abuse of routine stool microbiology: a College of American Pathologists Q-probes study of 601 institutions. , 1996, Archives of pathology & laboratory medicine.

[9]  A. Luberti,et al.  Yield from stool testing of pediatric inpatients. , 1997, Archives of pediatrics & adolescent medicine.

[10]  S. A. Schroeder,et al.  Variation among Physicians in Use of Laboratory Tests II. Relation to Clinical Productivity and Outcomes of Care , 1977, Medical care.

[11]  Gary W Procop,et al.  Reducing duplicate testing: a comparison of two clinical decision support tools. , 2015, American journal of clinical pathology.

[12]  K. Carroll,et al.  Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories , 2013, Clinical Microbiology Reviews.

[13]  Gary W Procop,et al.  Duplicate laboratory test reduction using a clinical decision support tool. , 2014, American journal of clinical pathology.

[14]  J. Aponte,et al.  Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. , 2001, JAMA.

[15]  C. Polage,et al.  Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.